Document is current
Any future updates will be listed below
-
Authors
Słonimska, Paulina
Baczyński-Keller, Jakub
Płatek, Rafał
Deptuła, Milena
Dzierżyńska, Maria
Sawicka, Justyna
Król, Oliwia
Sosnowski, Paweł
Koczkowska, Magdalena
Kostecka, Anna
Crossman, David K.
Crowley, Michael R.
Sass, Piotr
Smoleński, Ryszard Tomasz
Skowron, Piotr M.
Piotrowski, Arkadiusz
Pikuła, Michał
Rodziewicz-Motowidło, Sylwia
Sachadyn, Paweł
-
Funding
Funding for this research was provided by:
Narodowe Centrum Badań i Rozwoju (“BIONANOVA”, No. TECHMATSTRATEG2/410747/11/NCBR/2019., “BIONANOVA”, No. TECHMATSTRATEG2/410747/11/NCBR/2019., “BIONANOVA”, No. TECHMATSTRATEG2/410747/11/NCBR/2019., “BIONANOVA”, No. TECHMATSTRATEG2/410747/11/NCBR/2019., “BIONANOVA”, No. TECHMATSTRATEG2/410747/11/NCBR/2019.)
- License Information
-
More Information
Article History
Received: 2 August 2025
Accepted: 29 September 2025
First Online: 29 October 2025
Declarations
:
: Alginate-based pharmaceutical compositions of zebularine and retinoic acid to stimulate tissue regeneration are protected by patent No. Pat. 246411 (PL246411B1) granted by the Patent Office of the Republic of Poland. A related patent application, No. EP22214353.9 A has been filed with the European Patent Office. The authors declare no other potential competing interests.
